抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体

Anti-Fibrinogen Like Protein 1 (FGL1) Polyclonal Antibody

FGL-1; HFREP1; HP-041; LFIRE1; Hepassocin; Hepatocyte-derived fibrinogen-related protein 1; Liver fibrinogen-related protein 1

  • 抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体 产品包装(模拟)
  • 抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体 产品包装(模拟)
  • 抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体 Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20µg/ml rabbit Anti-human FGL1 Polyclonal Antibody (Catalog FAD022Hu01, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1µg/ml FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

用法

Flow cytometry: 20µg/ml;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过一年。避免反复冻融。

赠品

相关产品

编号 适用物种：Homo sapiens (Human，人) 应用(仅供研究使用，不用于临床诊断！)
UAPD022Hu61 纤维蛋白原相关蛋白1(FGL1)活性蛋白 Cell culture; Activity Assays.
UEPD022Hu41 纤维蛋白原相关蛋白1(FGL1)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UEPD022Hu62 纤维蛋白原相关蛋白1(FGL1)真核蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
URPD022Hu01 纤维蛋白原相关蛋白1(FGL1)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
UPAD022Hu01 纤维蛋白原相关蛋白1(FGL1)多克隆抗体 WB; IHC
UFAD022Hu01 抗纤维蛋白原相关蛋白1(FGL1)多克隆抗体 FCM
ULAD022Hu71 纤维蛋白原相关蛋白1(FGL1)多克隆抗体(生物素标记) WB; IHC; ICC.
ULAD022Hu81 纤维蛋白原相关蛋白1(FGL1)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
UMAD022Hu22 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 WB
UMAD022Hu23 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 WB
UMAD022Hu24 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 WB
UMAD022Hu21 纤维蛋白原相关蛋白1(FGL1)单克隆抗体 WB; IHC
USED022Hu 纤维蛋白原相关蛋白1(FGL1)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
ULMD022Hu 纤维蛋白原相关蛋白1(FGL1)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.
UKSD022Hu01 纤维蛋白原相关蛋白1(FGL1)检测试剂盒DIY材料(酶联免疫吸附试验法) Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志 参考文献
J Hepatol. The role of Hepassocin in the development of non-alcoholic fatty liver disease [Pubmed: 23792031]
Diabetes Management Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease [Futuremedicine:Source]
United States Patent Application Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html]
Cell Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC [Doi: 10.1016/j.cell.2018.09.053]
Liver Research Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus? []
Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus []
留言咨询